Eyantra Ventures publishes NCLT 3A ad for Prismberry scheme
Eyantra Ventures Limited published the Form NCLT 3A advertisement for its scheme of arrangement with Prismberry Technologies Private Limited. The petition, filed under Sections 230 to 232 of the Companies Act, 2013, was admitted by the NCLT Hyderabad Bench II on August 14, 2026. The hearing is scheduled for October 9, 2026.

*this image is generated using AI for illustrative purposes only.
Eyantra Ventures Limited has published the newspaper advertisement in Form No. NCLT 3A detailing its petition for a scheme of arrangement with Prismberry Technologies Private Limited. The move follows an order dated August 14, 2026, from the National Company Law Tribunal (NCLT), Hyderabad Bench II.
The scheme involves the amalgamation of Prismberry Technologies, the transferor company, with Eyantra Ventures, the transferee company. The joint petition was presented under Sections 230 to 232 of the Companies Act, 2013, on July 28, 2026. The advertisement was published on August 19, 2026, in Financial Express and Prajasakti.
Key Dates and Details
| Event | Date |
|---|---|
| Petition Presented | July 28, 2026 |
| Petition Admitted | August 14, 2026 |
| Advertisement Published | August 19, 2026 |
| Hearing Fixed | October 9, 2026 |
The petition is now fixed for hearing before the NCLT, Hyderabad Bench II, on October 9, 2026. Any person desirous of supporting or opposing the petition must send notice to the tribunal and the petitioners' registered office at least two days before the hearing date.
Prismberry Technologies is represented by Whole-time Director Manoj Kumar Yadav, while Eyantra Ventures is represented by Chairperson and Managing Director Vinita Raj Narayanam.
Historical Stock Returns for Eyantra Ventures
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.97% | -0.42% | -2.45% | -26.16% | -24.51% | +3,266.20% |
What strategic synergies or market expansion goals are driving Eyantra Ventures to acquire Prismberry Technologies?
How might the amalgamation impact Eyantra Ventures' financial metrics, such as revenue growth and debt-to-equity ratios, in the post-merger period?
Are there any anticipated regulatory hurdles or shareholder dissent that could delay the NCLT approval scheduled for October 9, 2026?


































